Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROE

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Nymox Pharmaceutical (NASDAQ: NYMX) is 90.50%. Nymox Pharmaceutical's revenue for the same period is $3.20 million.

The trailing-twelve-month return on equity at IDEXX Laboratories (NASDAQ: IDXX) is 44.30%. IDEXX Laboratories' operating margin for the same period is 19.60%.

The trailing-twelve-month return on equity at Meridian Bioscience (NASDAQ: VIVO) is 24.20%. Meridian Bioscience's PEG ratio is 1.78.

The trailing-twelve-month return on equity at Neogen (NASDAQ: NEOG) is 20.10%. Neogen's EPS for the same period is $0.75.